2022 annual financial data
Coherus Oncology 2022 Operating margin
Coherus Oncology 2022 operating margin with verified reported values.
Direct answer
Operating margin was -121.72%.
Operating income was -256,880,000 USD and net income was -291,754,000 USD.
Operating cash flow was -241,124,000 USD.
Get free Coherus Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 211,042,000 USD
- Operating income
- -256,880,000 USD
- Net income
- -291,754,000 USD
- Operating cash flow
- -241,124,000 USD